OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
10
Results
Show all
Save search
Copy query
Show results for
Unknown
(10)
Release Date
2022
(3)
2025
(2)
2024
(2)
2023
(1)
2021
(1)
2019
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Prognostic Value of G8 Geriatric Screening and Meet-URO Scores in Metastatic Renal Cell Carcinoma Patients Receiving First-Line Ipilimumab-Nivolumab Combination Immunotherapy.
Not available
S-EPMC11848895
|
biostudies-literature
Cite
Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer.
Not available
S-EPMC6868703
|
biostudies-literature
Cite
The impact of UEFA Euro 2020 football championship on Takotsubo Syndrome: Results of a multicenter national registry.
Not available
S-EPMC9554214
|
biostudies-literature
Cite
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program.
Not available
S-EPMC9808473
|
biostudies-literature
Cite
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort.
Not available
S-EPMC8134706
|
biostudies-literature
Cite
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group.
Not available
S-EPMC9251337
|
biostudies-literature
Cite
Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group.
Not available
S-EPMC10420921
|
biostudies-literature
Cite
Diagnosis and Screening Strategies for Detection of Familial Hypercholesterolaemia in Children and Adolescents in Italy: A Survey from the LIPIGEN Paediatric Group.
Not available
S-EPMC11941534
|
biostudies-literature
Cite
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Not available
S-EPMC11026312
|
biostudies-literature
Cite
Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2
EV
Study.
Not available
S-EPMC11557677
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets